Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
84
PharmaCompass offers a list of 2-Ethoxybenzamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 2-Ethoxybenzamide manufacturer or 2-Ethoxybenzamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 2-Ethoxybenzamide manufacturer or 2-Ethoxybenzamide supplier.
PharmaCompass also assists you with knowing the 2-Ethoxybenzamide API Price utilized in the formulation of products. 2-Ethoxybenzamide API Price is not always fixed or binding as the 2-Ethoxybenzamide Price is obtained through a variety of data sources. The 2-Ethoxybenzamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ethenzamid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethenzamid, including repackagers and relabelers. The FDA regulates Ethenzamid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethenzamid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ethenzamid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ethenzamid supplier is an individual or a company that provides Ethenzamid active pharmaceutical ingredient (API) or Ethenzamid finished formulations upon request. The Ethenzamid suppliers may include Ethenzamid API manufacturers, exporters, distributors and traders.
click here to find a list of Ethenzamid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ethenzamid Drug Master File in Japan (Ethenzamid JDMF) empowers Ethenzamid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ethenzamid JDMF during the approval evaluation for pharmaceutical products. At the time of Ethenzamid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ethenzamid suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ethenzamid Drug Master File in Korea (Ethenzamid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ethenzamid. The MFDS reviews the Ethenzamid KDMF as part of the drug registration process and uses the information provided in the Ethenzamid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ethenzamid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ethenzamid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ethenzamid suppliers with KDMF on PharmaCompass.
Ethenzamid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ethenzamid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethenzamid GMP manufacturer or Ethenzamid GMP API supplier for your needs.
A Ethenzamid CoA (Certificate of Analysis) is a formal document that attests to Ethenzamid's compliance with Ethenzamid specifications and serves as a tool for batch-level quality control.
Ethenzamid CoA mostly includes findings from lab analyses of a specific batch. For each Ethenzamid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ethenzamid may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethenzamid EP), Ethenzamid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethenzamid USP).
